Indication

Citrullinemia

Citrullinemia is a rare, autosomal recessive inborn error of metabolism belonging to the family of urea cycle disorders. Read more about Citrullinemia

40 drugs 27 manufacturers

Advertisement

Drugs that treat it

Common Citrullinemia therapies.

Showing 28–36 of 40 drugs

SODIUM PHENYLBUTYRATE

UREA CYCLE DISORDER AGENTS·CARBAMOYL PHOSPHATE SYNTHETASE DEFICIENCY·+2
GLENMARK PHARMA
Filter & compare in the drug finder →Opens the drug finder with Citrullinemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Citrullinemia.

Citrullinemia is a rare, autosomal recessive inborn error of metabolism belonging to the family of urea cycle disorders.

It primarily impairs the hepatic clearance of waste nitrogen, leading to profound systemic hyperammonemia and the toxic accumulation of citrulline and other metabolites in the blood, urine, and cerebrospinal fluid.

The condition encompasses type I (classic citrullinemia, caused by argininosuccinate synthetase deficiency) and type II (citrin deficiency), which affect both pediatric and adult populations.

Clinically, it presents across a spectrum ranging from catastrophic neonatal encephalopathy—characterized by lethargy, poor feeding, seizures, cerebral edema, and coma—to later-onset neuropsychiatric manifestations, ataxia, and hepatic dysfunction triggered by metabolic stress or catabolism.

Personalize your experience

Follow Citrullinemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it